Swiss pharmaceuticals giant Novartis announced over the weekend it would dish out $9.7 billion (8.8 billion euros) to acquire US
Read moreHome »
Novartis Breast Cancer Drug Cuts Risk Of Death By 35 Percent In Patients With PIK3CA Gene Mutation
An experimental breast cancer drug by Switzerland-based drugmaker Novartis cuts the risk of death or disease progression by more than
Read more